FDA’s “Belt and Suspenders” Approach to Mifepristone Approval
Political pressure and wary regulators shaped FDA’s mifepristone approval in 2000.
Centering Children in Public Health Regulation
Scholar proposes an increased focus on children’s health in food, drug, and cosmetic regulation.
Ethical Considerations for FDA Accelerated Approval
Scholars debate ways to improve FDA’s accelerated approval mechanism.
Navigating the Challenges of Publicizing Social Media Data
Scholars argue that data-sharing lessons from clinical trials can apply to social media.
An Intersectional Approach to Regulating Women’s Health
Scholar calls for regulators to correct the dangers of inadequate cosmetics regulations for women of color.
Regulating Weight-Loss Drugs and Supplements
Scholars discuss the regulatory landscape surrounding GLP-1 drugs and dietary supplements.
Drilling Down on Loper Bright and Health Care Regulation
The Loper Bright decision leaves hundreds of pivotal health care regulations subject to litigation.
The Underregulation of Carcinogen Exposure
Scholar calls for Congress to empower regulators to limit exposure to cancer-causing chemicals.
Reducing Barriers to Glucose Monitoring
FDA approves first over-the-counter continuous glucose monitor for U.S. patients.
Regulating Agricultural Water Quality
Contaminated agricultural water is a well-known root cause of foodborne illness that regulators have struggled to address.
FDA Targets Toxic Soda Ingredients
FDA proposes a rule that would prohibit the use of a toxic food additive in sodas.
